Advances in Industrial Biotechnology Using CRISPR-Cas Systems

Trends in Biotechnology

Volumn 36, Issue 2, 2018, Pages 134-146

  Donohoue, Paul D ^a   Barrangou, Rodolphe ^b   May, Andrew P ^a,c  

^a Caribou Biosciences Inc   (United States)

^b NORTH CAROLINA STATE UNIVERSITY   (United States)

^c CHAN ZUCKERBERG BIOHUB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ENGINEERING; IMMUNIZATION; INDUSTRIAL CHEMICALS; INDUSTRIAL PLANTS; MICROORGANISMS; NUCLEIC ACIDS; PRECISION ENGINEERING; RNA; TRANSCRIPTION;

BIOCHEMICAL SYNTHESIS; FUNDAMENTAL CHARACTERISTICS; INDUSTRIAL BIOTECHNOLOGY; INDUSTRIAL PRODUCTION; INDUSTRIAL SETTINGS; METABOLIC PATHWAYS; MICROBIAL ENGINEERINGS; TECHNICAL EXPERTISE;

INDUSTRIAL RESEARCH;

CELLULAR APOPTOSIS SUSCEPTIBILITY PROTEIN; CRISPR ASSOCIATED PROTEIN; DNA; NUCLEASE; RNA; BACTERIAL PROTEIN; CAS9 ENDONUCLEASE STREPTOCOCCUS PYOGENES; ENDONUCLEASE; GUIDE RNA;

ADAPTIVE IMMUNITY; BIOTECHNOLOGY; CRISPR CAS SYSTEM; DNA END JOINING REPAIR; ENZYME INACTIVATION; GENE KNOCKOUT; GENETIC ENGINEERING; GENETIC TRANSCRIPTION; GENOME; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; REVIEW; ANIMAL; GENE EDITING; GENETICS; METABOLISM; MICROBIOLOGY; PLANT; PROCEDURES;

ANIMALS; BACTERIAL PROTEINS; BIOTECHNOLOGY; CRISPR-CAS SYSTEMS; ENDONUCLEASES; GENE EDITING; GENETIC ENGINEERING; INDUSTRIAL MICROBIOLOGY; METABOLIC NETWORKS AND PATHWAYS; PLANTS; RNA, GUIDE;

EID: 85026534475     PISSN: 01677799     EISSN: 18793096     Source Type: Journal    
DOI: 10.1016/j.tibtech.2017.07.007     Document Type: Review

References (107)

1. Esvelt, K.M., Wang, H.H., Genome-scale engineering for systems and synthetic biology. Mol. Syst. Biol. 9 (2013), 1–17.
2. David, F., Siewers, V., Advances in yeast genome engineering. FEMS Yeast Res. 15 (2015), 1–14.
3. Barrangou, R., et al. CRISPR provides acquired resistance against viruses in prokaryotes. Science 315 (2007), 1709–1712.
4. Horwitz, A.A., et al. Efficient multiplexed integration of synergistic alleles and metabolic pathways in yeasts via CRISPR-Cas. Cell Syst. 1 (2015), 1–9.
5. Jiang, W., et al. RNA-guided editing of bacterial genomes using CRISPR-Cas systems. Nat. Biotechnol. 31 (2013), 233–239.
6. Jiang, Y., et al. Multigene editing in the Escherichia coli genome via the CRISPR-Cas9 system. Appl. Environ. Microbiol. 81 (2015), 2506–2514.
7. Ronda, C., et al. CrEdit: CRISPR mediated multi-loci gene integration in Saccharomyces cerevisiae. Microb. Cell Fact. 14 (2015), 1–11.
8. Mans, R., et al. CRISPR/Cas9: a molecular Swiss army knife for simultaneous introduction of multiple genetic modifications in Saccharomyces cerevisiae. FEMS Yeast Res. 15 (2015), 1–15.
9. Qi, L.S., et al. Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression. Cell 152 (2013), 1173–1183.
10. Gilbert, L.A., et al. CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes. Cell 154 (2013), 1–10.
11. Bikard, D., Marraffini, L.a, Control of gene expression by CRISPR-Cas systems. F1000Prime Rep. 5 (2013), 1–8.
12. Nielsen, A.A.K., Voigt, C.A., Multi-input CRISPR/Cas genetic circuits that interface host regulatory networks. Mol. Syst. Biol. 10 (2014), 1–11.
13. Didovyk, A., et al. Orthogonal modular gene repression in Escherichia coli using engineered CRISPR/Cas9. ACS Synth. Biol. 5 (2016), 81–88.
14. Gander, M.W., et al. Robust digital logic circuits in eukaryotic cells with CRISPR/dCas9 NOR gates. bioRxiv., 2016, 10.1101/041871 Published online March 2, 2016.
15. Burstein, D., et al. CRISPR-Cas viral defence systems. Nat. Commun. 7 (2016), 1–8.
16. van der Oost, J., et al. Unravelling the structural and mechanistic basis of CRISPR-Cas systems. Nat. Rev. Microbiol. 12 (2015), 479–492.
17. Westra, E.R., et al. CRISPR-Cas systems: beyond adaptive immunity. Nat. Rev. Microbiol. 12 (2014), 317–326.
18. Nuñez, J.K., et al. Cas1-Cas2 complex formation mediates spacer acquisition during CRISPR-Cas adaptive immunity. Nat. Struct. Mol. Biol. 21 (2014), 528–534.
19. Horvath, P. et al. (2008) Diversity, activity, and evolution of CRISPR loci in Streptococcus thermophilus. 190, 1401–1412.
20. Mojica, F.J.M., et al. Short motif sequences determine the targets of the prokaryotic CRISPR defence system. Microbiology 155 (2008), 733–740.
21. Deltcheva, E., et al. CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III. Nature 471 (2011), 602–607.
22. Jinek, M., et al. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337 (2012), 816–822.
23. Makarova, K.S., et al. An updated evolutionary classification of CRISPR-Cas systems. Nat. Rev. Microbiol. 13 (2015), 722–736.
24. Shmakov, S., et al. Diversity and evolution of class 2 CRISPR–Cas systems. Nat. Rev. Microbiol. 15 (2017), 169–182.
25. Zetsche, B., et al. Cpf1 is a single RNA-guided endonuclease of a Class 2 CRISPR-Cas system. Cell 163 (2015), 759–771.
26. Abudayyeh, O.O., et al. C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector. Science 353 (2016), 1–17.
27. Burstein, D., et al. New CRISPR-Cas systems from uncultivated microbes. Nature 542 (2016), 237–241.
28. Shmakov, S., et al. Discovery and functional characterization of article discovery and functional characterization of diverse Class 2 CRISPR-Cas systems. Mol. Cell 60 (2015), 385–397.
29. Smargon, A., et al. Cas13b is a Type VI-B CRISPR-associated RNA-guided RNase differentially regulated by accessory proteins Csx27 and Csx28. Mol. Cell, 65, 2016 618–630.e7.
30. Garneau, J.E., et al. The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA. Nature 468 (2010), 67–71.
31. Sapranauskas, R., et al. The Streptococcus thermophilus CRISPR/Cas system provides immunity in Escherichia coli. Nucleic Acids Res. 39 (2011), 9275–9282.
32. Gasiunas, G., et al. Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria. Proc. Natl. Acad. Sci. U. S. A. 109 (2012), 2579–2586.
33. Friedland, A.E., et al. Heritable genome editing in C. elegans via a CRISPR-Cas9 system. Nat Methods 10 (2014), 741–743.
34. Bassett, A.R., et al. Highly efficient targeted mutagenesis of Drosophila with the CRISPR/Cas9 system. Cell Rep. 4 (2013), 220–228.
35. Li, J.-F., et al. Multiplex and homologous recombination-mediated genome editing in Arabidopsis and Nicotiana benthamiana using guide RNA and Cas9. Nat. Biotechnol. 31 (2013), 688–691.
36. Jinek, M., et al. RNA-programmed genome editing in human cells. Elife 2013 (2013), 1–9.
37. Mali, P., et al. RNA-guided human genome engineering via Cas9. Science 339 (2013), 823–826.
38. Cong, L., et al. Multiplex genome engineering using CRISPR/Cas systems. Science 339 (2013), 819–823.
39. Wang, H., et al. One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering. Cell 153 (2013), 910–918.
40. DiCarlo, J.E., et al. Genome engineering in Saccharomyces cerevisiae using CRISPR-Cas systems. Nucleic Acids Res. 41 (2013), 4336–4343.
41. Nødvig, C.S., et al. A CRISPR-Cas9 system for genetic engineering of filamentous fungi. PLoS One 10 (2015), 1–18.
42. Timme, R.E., et al. Phylogenetic diversity of the enteric pathogen Salmonella enterica subsp. enterica inferred from genome-wide reference-free SNP characters. Genome Biol. Evol. 5 (2013), 2109–2123.
43. Sheludchenko, M.S., et al. CRISPR diversity in E. coli isolates from Australian animals, humans and environmental waters. PLoS One 10 (2015), 1–12.
44. Kamerbeek, J., et al. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J. Clin. Microbiol. 35 (1997), 907–914.
45. Shariat, N. and Dudley, E.G. (2014) CRISPRs: molecular signatures used for pathogen subtyping. 80, 430–439.
46. Briner, A.E., Barrangou, R., Lactobacillus buchneri genotyping on the basis of clustered regularly interspaced short palindromic repeat (CRISPR) locus diversity. Appl. Environ. Microbiol. 80 (2014), 994–1001.
47. Barrangou, R., et al. Genomic impact of CRISPR immunization against bacteriophages. Biochem. Soc. Trans. 41 (2013), 1383–1391.
48. Selle, K., Barrangou, R., Harnessing CRISPR-Cas systems for bacterial genome editing. Trends Microbiol. 23 (2015), 225–232.
49. Bikard, D., et al. Development of sequence-specific antimicrobials based on programmable CRISPR-Cas nucleases. Nat. Biotechnol. 32 (2015), 1146–1150.
50. Gomaa, A.A., et al. Programmable removal of bacterial strains by use of genome-targeting CRISPR-Cas Systems. MBio 5 (2014), 1–9.
51. Citorik, R.J., et al. Sequence-specific antimicrobials using efficiently delivered RNA-guided nucleases. Nat. Biotechnol. 32 (2014), 1141–1145.
52. Yosef, I. et al. (2015) Temperate and lytic bacteriophages programmed to sensitize and kill antibiotic-resistant bacteria. 2015.
53. Vercoe, R.B., et al. Cytotoxic chromosomal targeting by CRISPR/Cas systems can reshape bacterial genomes and expel or remodel pathogenicity islands. PLoS Genet. 9 (2013), 1–13.
54. Caliando, B.J., Voigt, C.a, Targeted DNA degradation using a CRISPR device stably carried in the host genome. Nat. Commun., 6, 2015, 6989.
55. Bikard, D. et al. (2012) CRISPR interference can prevent natural transformation and virulence acquisition during in vivo bacterial infection. 12, 177–186.
56. Sinkunas, T., et al. In vitro reconstitution of Cascade-mediated CRISPR immunity in Streptococcus thermophilus. EMBO J. 32 (2013), 385–394.
57. Jakočinas, T., et al. Multiplex metabolic pathway engineering using CRISPR/Cas9 in Saccharomyces cerevisiae. Metab. Eng. 28 (2015), 213–222.
58. Liu, R., et al. Efficient genome editing in filamentous fungus Trichoderma reesei using the CRISPR/Cas9 system. Cell Discov., 1, 2015, 15007.
59. Rong, Z., et al. Homologous recombination in human embryonic stem cells using CRISPR/Cas9 nickase and a long DNA donor template. Protein Cell 5 (2014), 258–260.
60. Jacobs, J.Z., et al. Implementation of the CRISPR-Cas9 system in fission yeast. Nat. Commun., 5, 2014, 5344.
61. Min, K., et al. Candida albicans gene deletion with a transient CRISPR-Cas9 system. Host-Microbe Biol. 1 (2015), 1–9.
62. Zhang, C., et al. Highly efficient CRISPR mutagenesis by microhomology-mediated end joining in Aspergillus fumigatus. Fungal Genet. Biol. 86 (2016), 47–57.
63. Matsu-ura, T., et al. Efficient gene editing in Neurospora crassa with CRISPR technology. Fungal Biol. Biotechnol. 2 (2015), 1–7.
64. Arazoe, T., et al. Tailor-made CRISPR/Cas system for highly efficient targeted gene replacement in the rice blast fungus. Biotechnol. Bioeng. 112 (2015), 2543–2549.
65. Pohl, C., et al. CRISPR/Cas9 based genome editing of Penicillium chrysogenum. ACS Synth. Biol. 5 (2016), 754–764.
66. Mali, P., et al. CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering. Nat. Biotechnol. 31 (2013), 833–838.
67. Singh, A.K., et al. Investigating essential gene function in Mycobacterium tuberculosis using an efficient CRISPR interference system. Nucleic Acids Res. 44 (2016), 3–13.
68. Tong, Y., et al. CRISPR-Cas9 based engineering of actinomycetal genomes. ACS Synth. Biol. 4 (2015), 1020–1029.
69. Smith, J.D., et al. Quantitative CRISPR interference screens in yeast identify chemical-genetic interactions and new rules for guide RNA design. Genome Biol. 17 (2016), 1–16.
70. Bikard, D., et al. Programmable repression and activation of bacterial gene expression using an engineered CRISPR-Cas system. Nucleic Acids Res. 41 (2013), 7429–7437.
71. Zalatan, J., et al. Engineering complex synthetic transcriptional programs with CRISPR RNA scaffolds. Cell 160 (2015), 339–350.
72. Staals, R.H.J., et al. RNA targeting by the Type III-A CRISPR-Cas Csm complex of Thermus thermophilus. Mol. Cell 56 (2014), 518–530.
73. Sternberg, S.H., et al. DNA interrogation by the CRISPR RNA-guided endonuclease Cas9. Nature 507 (2014), 62–67.
74. Cress, B.F., et al. Rapid generation of CRISPR/dCas9-regulated, orthogonally repressible hybrid T7-lac promoters for modular, tuneable control of metabolic pathway fluxes in Escherichia coli. Nucleic Acids Res. 44 (2016), 4472–4485.
75. Harrington, L.B., et al. A thermostable Cas9 with increased lifetime in human plasma. bioRxiv, 2017, 10.1101/138867 Published online May 16, 2017.
76. Anders, C., et al. Structural plasticity of PAM recognition by engineered variants of the RNA-guided endonuclease Cas9. Mol. Cell 61 (2016), 895–902.
77. Kleinstiver, B.P., et al. Engineered CRISPR-Cas9 nucleases with altered PAM specificities. Nature 523 (2015), 481–485.
78. Hirano, H., et al. Structure and engineering of Francisella novicida Cas9 Hisato. Cell 21 (2016), 193–201.
79. Zargar, K., et al. In vitro characterization of phenylacetate decarboxylase, a novel enzyme catalyzing toluene biosynthesis in an anaerobic microbial community. Sci. Rep., 6, 2016, 31362.
80. Mougiakos, I., et al. Efficient genome editing of a facultative thermophile using mesophilic spCas9. ACS Synth. Biol. 6 (2017), 849–861.
81. Altenbuchner, J., Editing of the Bacillus subtilis genome by the CRISPR-Cas9 system. Appl. Environ. Microbiol. 2 (2016), 5421–5427.
82. Nagaraju, S., et al. Genome editing of Clostridium autoethanogenum using CRISPR/Cas9. Biotechnol. Biofuels, 9, 2016, 219.
83. Wang, Y., et al. Markerless chromosomal gene deletion in Clostridium beijerinckii using CRISPR/Cas9 system. J. Biotechnol. 200 (2015), 1–5.
84. Wang, Y., et al. Bacterial genome editing with CRISPR-Cas9: deletion, integration, single nucleotide modification, and desirable ‘clean’ mutant selection in Clostridium beijerinckii as an example. ACS Synth. Biol. 5 (2016), 721–732.
85. Xu, T., et al. Efficient genome editing in clostridium cellulolyticum via CRISPR-Cas9 nickase. Appl. Environ. Microbiol. 81 (2015), 4423–4431.
86. Cleto, S., et al. Corynebacterium glutamicum metabolic engineering with CRISPR interference (CRISPRi). ACS Synth. Biol. 5 (2016), 375–385.
87. Huang, H., et al. CRISPR/Cas9-based efficient genome editing in Clostridium ljungdahlii, an autotrophic gas-fermenting bacterium. ACS Synth. Biol. 5 (2016), 1355–1361.
88. Pyne, M.E., et al. Harnessing heterologous and endogenous CRISPR-Cas machineries for efficient markerless genome editing in Clostridium. Sci. Rep. 6 (2016), 1–15.
89. Pyne, M.E., et al. Coupling the CRISPR/Cas9 system with lambda red recombineering enables simplified chromosomal gene replacement in Escherichia coli. Appl. Environ. Microbiol. 81 (2015), 5103–5114.
90. Standage-Beier, K., et al. Targeted large-scale deletion of bacterial genomes using CRISPR-nickases. ACS Synth. Biol. 4 (2015), 1217–1225.
91. Ronda, C., et al. CRMAGE: CRISPR optimized MAGE recombineering. Sci. Rep., 6, 2016, 19452.
92. Cress, B.F., et al. Sensitive cells: enabling tools for static and dynamic control of microbial metabolic pathways. Curr. Opin. Biotechnol. 36 (2015), 205–214.
93. Rath, D., et al. Efficient programmable gene silencing by Cascade. Nucleic Acids Res. 43 (2014), 237–246.
94. Oh, J.-H., van Pijkeren, J.-P., CRISPR-Cas9-assisted recombineering in Lactobacillus reuteri. Nucleic Acids Res. 42 (2014), 1–11.
95. Cobb, R.E., et al. High-efficiency multiplex genome editing of Streptomyces species using an engineered CRISPR/Cas system. ACS Synth. Biol. 4 (2014), 723–728.
96. Tsai, S., et al. An isolated Candida albicans TL3 capable of degrading phenol at large concentration. Biosci. Biotechnol. Biochem. 69 (2014), 2358–2367.
97. Vyas, V., et al. A Candida albicans CRISPR system permits genetic engineering of essential genes and gene families. Sci. Adv., 1, 2015, e1500248.
98. Weninger, A., et al. Combinatorial optimization of CRISPR/Cas9 expression enables precision genome engineering in the methylotrophic yeast Pichia pastoris. J. Biotechnol. 235 (2016), 139–149.
99. Biot-Pelletier, D., Martin, V.J.J., Seamless site-directed mutagenesis of the Saccharomyces cerevisiae genome using CRISPR-Cas9. J. Biol. Eng, 10, 2016, 6.
100. Ryan, O.W., et al. Selection of chromosomal DNA libraries using a multiplex CRISPR system. Elife, 3, 2014, e03703.
101. Bao, Z., et al. Homology-integrated CRISPR-Cas (HI-CRISPR) system for one-step multigene disruption in Saccharomyces cerevisiae. ACS Synth. Biol. 4 (2015), 585–594.
102. Geiser, E., et al. Prospecting the biodiversity of the fungal family Ustilaginaceae for the production of value-added chemicals. Fungal Biol. Biotechnol., 1, 2014, 2.
103. Schuster, M., et al. Genome editing in Ustilago maydis using the CRISPR-Cas system. Fungal. Genet. Biol. 89 (2016), 3–9.
104. Gao, S., et al. Multiplex gene editing of the Yarrowia lipolytica genome using the CRISPR-Cas9 system. J. Ind. Microbiol. Biotechnol. 43 (2016), 1085–1093.
105. Schwartz, C., et al. Standardized markerless gene integration for pathway engineering in Yarrowia lipolytica. ACS Synth. Biol. 6 (2016), 402–409.
106. Katayama, T., et al. Development of a genome editing technique using the CRISPR/Cas9 system in the industrial filamentous fungus Aspergillus oryzae. Biotechnol. Lett. 38 (2016), 637–642.
107. Liu, Q., et al. Biotechnology for biofuels development of a genome-editing CRISPR/Cas9 system in thermophilic fungal Myceliophthora species and its application to hyper-cellulase production strain engineering. Biotechnol. Biofuels 10 (2017), 1–14.